Trial Profile
A randomized, open-label, comparative evaluation of conversion from calcineurin inhibitors [ciclosporin] to sirolimus versus continued use of calcineurin inhibitors in renal allograft recipient
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Azathioprine; Ciclosporin; Methylprednisolone; Mycophenolate mofetil; Mycophenolate sodium; Prednisolone; Prednisone; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Wyeth
- 06 Jun 2007 New trial record.